A partial nephrectomy is surgery to remove a tumor or diseased portion of a kidney while leaving the healthy tissue intact. It is the recommended treatment for kidney tumors smaller than 7 centimeters (about 2.8 inches) that are still confined to the kidney, and it’s increasingly considered the gold standard over removing the entire kidney when technically feasible.
The core goal is straightforward: take out all the abnormal tissue with clean margins while preserving as much working kidney as possible. That preservation of kidney function is what makes this approach so valuable, especially for people who have only one functioning kidney, have kidney disease, or may face future kidney problems.
Why Surgeons Prefer Saving the Kidney
For decades, the standard treatment for kidney cancer was radical nephrectomy, which removes the entire kidney. Partial nephrectomy emerged as research showed that patients who kept more kidney tissue had better long-term health outcomes. One year after surgery, patients who had a partial nephrectomy maintained an average kidney filtration rate of 71 mL/min, compared to 52 mL/min for those who lost the whole kidney. That gap matters because lower kidney function raises the risk of cardiovascular disease, metabolic problems, and reduced quality of life over time.
In the first five years after surgery, patients who had partial nephrectomy had a significantly lower risk of death from any cause compared to those who had the whole kidney removed. Interestingly, that survival advantage didn’t extend beyond five years, and long-term rates of dialysis and cardiovascular events were similar between the two groups. Still, preserving kidney function gives your body more resilience if you ever develop kidney problems later in life, which is why both American and European urology guidelines now recommend partial nephrectomy for all tumors in the T1 stage (up to 7 cm, confined to the kidney).
Who Is a Candidate
The best candidates have a single, small tumor that sits in an accessible location on the kidney. Tumors under 4 centimeters (about 1.5 inches) are the most straightforward cases, and most surgeons will recommend a partial nephrectomy as the first option. Tumors between 4 and 7 centimeters can also be treated this way, though the decision depends more heavily on where exactly the tumor sits and how deeply it extends into the kidney.
Surgeons use scoring systems to assess tumor complexity before operating. These scores factor in tumor size, how close it is to the kidney’s collecting system and blood vessels, and whether it grows inward or outward. Tumors are grouped into low complexity (scores 4 to 6), moderate complexity (7 to 9), and high complexity (10 or above). Higher complexity scores predict longer operative times, more blood loss, and a greater chance the surgeon may need to convert to a full kidney removal during the procedure. That said, even moderately complex tumors are routinely treated with partial nephrectomy at experienced centers.
Three Surgical Approaches
Partial nephrectomy can be performed three ways: through a large incision (open surgery), through small incisions using a camera and long instruments (laparoscopic), or through small incisions with a robotic surgical system controlled by the surgeon. Each approach removes the same tissue. The differences are in recovery, blood loss, and precision.
Robotic and laparoscopic approaches result in roughly 100 mL of blood loss on average, compared to 250 mL for open surgery. Hospital stays are typically two days for robotic or laparoscopic procedures and three days for open surgery. Open surgery is faster on the operating table (around 147 minutes versus 190 to 195 minutes for minimally invasive approaches), but the smaller incisions of robotic and laparoscopic surgery mean less post-operative pain and quicker return to normal activity.
Complication rates are similar across all three approaches, with one notable exception: urine leaks. This is the most talked-about complication specific to partial nephrectomy, occurring when the kidney’s urine-collecting system is disrupted during tumor removal. The robotic approach has the lowest leak rate at about 0.75%, compared to 3.7% for open and 4.9% for laparoscopic surgery. For larger tumors (the T1b category, 4 to 7 cm), the difference is dramatic. Leak rates climb to 40% with open surgery but only 8.3% with the robotic approach, largely because the robotic system allows more precise reconstruction of the kidney.
What Happens During the Procedure
Regardless of the surgical approach, the critical step is temporarily clamping the blood vessels that feed the kidney. This creates a bloodless field so the surgeon can see clearly while cutting out the tumor and stitching the kidney closed. The kidney receives no blood flow during this window, which is called warm ischemia time.
Research from randomized trials shows that up to 10 minutes of clamping has no measurable impact on kidney function afterward. Beyond 10 minutes, there is a proportional decline in function, though in patients with two working kidneys, the clinical impact is generally small. Open surgery typically achieves the shortest clamp times (around 12 minutes) because the surgeon works directly with their hands, while robotic and laparoscopic approaches average 25 to 30 minutes. Surgeons at high-volume centers have steadily reduced these times, and some now perform the procedure with no clamping at all for smaller tumors.
Recovery Timeline
Most people go home within two to three days after surgery. For robotic or laparoscopic procedures, you can expect to resume light daily activities within one to two weeks. Open surgery typically requires a longer recovery window because of the larger incision through the abdominal wall muscles. Strenuous physical activity and heavy lifting are generally off-limits for four to six weeks regardless of the approach, to allow the kidney to heal internally.
Pain management after minimally invasive surgery is usually handled with oral medications within a day or two. A drain may be left near the kidney for a few days to catch any fluid that accumulates. You’ll have blood work done before discharge and at follow-up visits to track how well your remaining kidney tissue is filtering.
Cancer Control After Surgery
The oncological results of partial nephrectomy match those of removing the entire kidney for appropriately staged tumors. The goal during surgery is negative margins, meaning no cancer cells are found at the edge of the removed tissue. Positive margin rates are low across all approaches, ranging from 0% to about 7%, and even when a margin comes back positive, it does not always lead to recurrence.
Cancer-specific survival is equivalent between partial and radical nephrectomy for T1 tumors, which is precisely why guidelines now favor the kidney-sparing option. You get the same cancer control with the added benefit of keeping more functional kidney tissue.
Follow-Up After Surgery
After a partial nephrectomy for kidney cancer, you’ll enter a surveillance schedule that includes regular imaging and blood work. In the first two years, this typically involves CT scans or MRIs of the abdomen along with chest imaging to check for any spread. After two years, your doctor may alternate between ultrasound and cross-sectional imaging, depending on the risk level of your original tumor. After five years, the decision about whether to continue imaging becomes a shared conversation between you and your doctor based on your individual risk profile. Each follow-up visit also includes a physical exam and lab work to monitor kidney function.